Cargando…

Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study

BACKGROUND/AIMS: Serotonin receptor (eg, 5-HT(3)) antagonists are used to treat nausea and vomiting from a variety of causes. Granisetron transdermal system (GTS) is an appealing delivery system for patients with gastroparesis. To assess if GTS improves nausea and vomiting and other gastroparesis sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Midani, Deena, Parkman, Henry P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056574/ https://www.ncbi.nlm.nih.gov/pubmed/27400689 http://dx.doi.org/10.5056/jnm15203

Ejemplares similares

Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System
por: Jung, Hye-Kyung
Publicado: (2016)

Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)

Enhanced Transdermal Delivery of Granisetron by Using Iontophoresis
por: Panzade, Prabhakar, et al.
Publicado: (2012)

Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment
por: Jehangir, Asad, et al.
Publicado: (2017)

Taste and Smell Disturbances in Patients with Gastroparesis and Gastroesophageal Reflux Disease
por: Kabadi, Alisha, et al.
Publicado: (2017)

A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying
por: Moors, Victoria J., et al.
Publicado: (2022)

Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
por: Tuca, Albert
Publicado: (2009)

Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
por: Mason, Jay W, et al.
Publicado: (2013)

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
por: Li, Jiayu, et al.
Publicado: (2023)

Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis
por: McCallum, R W, et al.
Publicado: (2013)

Health‐care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis
por: Chen, Yaozhu J., et al.
Publicado: (2022)

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
por: Sun, Der Sheng, et al.
Publicado: (2023)

COVID-19 infection manifesting as a severe gastroparesis flare: A case report
por: Song, Jun, et al.
Publicado: (2021)

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy
por: Boccia, Ralph V, et al.
Publicado: (2012)

Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia
por: Koch, Kenneth L., et al.
Publicado: (2022)

The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
por: Revicki, Dennis A., et al.
Publicado: (2018)

Ultrastructural differences between diabetic and idiopathic gastroparesis
por: Faussone-Pellegrini, Maria Simonetta, et al.
Publicado: (2012)

Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis.
por: Carmichael, J., et al.
Publicado: (1994)

Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
por: Siraj, Elias S., et al.
Publicado: (2018)

Clinical predictors of symptom improvement failure in gastroparesis
por: Amjad, Waseem, et al.
Publicado: (2022)

Prevalence of Hidden Gastroparesis in the Community: The Gastroparesis "Iceberg"
por: Rey, Enrique, et al.
Publicado: (2012)

Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
por: Riviere, A.
Publicado: (1994)

Postoperative nausea and vomiting prophylaxis: A comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy
por: Gupta, Pushplata, et al.
Publicado: (2014)

Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment
por: Mandarino, Francesco Vito, et al.
Publicado: (2023)

Rectal Sensitivity in Diabetes Patients with Symptoms of Gastroparesis
por: Søfteland, Eirik, et al.
Publicado: (2014)

Gastroparesis
por: Miles, Matthew, et al.
Publicado: (2023)

Gastroparésie
por: Miles, Matthew, et al.
Publicado: (2023)

Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary
por: Fehnel, Sheri, et al.
Publicado: (2019)

Toward an Improved Treatment for Gastroparesis
por: Kim, Tae-Han
Publicado: (2020)

A pilot genome‐wide association study meta‐analysis of gastroparesis
por: Tavares, Leticia Camargo, et al.
Publicado: (2023)

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study
por: Boccia, Ralph V., et al.
Publicado: (2010)

Comparison the Effect of Granisetron and Dexamethasone on Intravenous Propofol Pain
por: Adinehmehr, Leili, et al.
Publicado: (2018)

Evaluation of prokinetic agents used in the treatment of gastroparesis
por: Roe, Neil A, et al.
Publicado: (2017)

Gastric electrical stimulation for treatment of clinically severe gastroparesis
por: Jayanthi, Naga Venkatesh G., et al.
Publicado: (2013)

Gastroparesis in children
por: Saliakellis, Efstratios, et al.
Publicado: (2013)

Diabetic Gastroparesis
por: Kalra, Sanjay, et al.
Publicado: (2018)

Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule
por: Bekkelund, Mattis, et al.
Publicado: (2021)

Influence of Gastric Emptying and Gut Transit Testing on Clinical Management Decisions in Suspected Gastroparesis
por: Hasler, William L., et al.
Publicado: (2019)

Recent Advances in the Pathophysiology and Treatment of Gastroparesis
por: Oh, Jung Hwan, et al.
Publicado: (2013)

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study
por: Wakasugi, Yoshinori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_54eu9h7kqtjr16fe4ojvrkjt3b